The News
Neosens closes a second funding round of €4M
21/04/2009
TOULOUSE, France I April 21st, 2009 - Neosens, specialized in monitoring solutions based on microelectronic sensors to monitor fouling and dissolved oxygen in water and industrial processes, announces the closing of a € 4 million capital round and the appointment of Thierry Brisard as CEO. The group of investors, led by Sofinnova Partners, includes the Belgian Capricorn Cleantech Fund and Galia Gestion, and the original investors, ICSO Private Equity and IRDI.
After a first round in December 2007, Neosens closed its second round of financing for € 4 million bringing the company’s capital to € 6.5 million. Founded in 2001 in Toulouse by Laurent Auret, Neosens develops and markets a new generation of measuring instruments with sensors based on Microsystems technologies for monitoring and measuring the quality of water and industrial liquids. The product list includes unique and revolutionary sensors for continuous, real-time and in-situ measurement of fouling (biofilm & scale) thickness inside industrial equipment carrying water or industrial liquids, as well as monitoring solutions for continuous measurement with automatic calibration of dissolved oxygen at very low levels (ppb) in water or hydrocarbons. In addition, Neosens develops new products and customized solutions for its customers through its technological platform. Neosens’ unique probes, equipped with miniaturized and easily integrated sensors, contain innovative features that respond to current issues faced by monitoring networks and industrial processes. Neosens’ products have proven themselves in industrial processes designed for the pulp & paper industry, the food & beverage industry, and in water treatment applications for cooling towers.
Along with this second fund raising, Laurent Auret decided to leave his position as CEO for the management of Strategic Development and Innovation. Thierry Brisard took on the function of CEO in order to ensure the overall and international development of the company. After his experience as General Manager at Nalco (specialty chemicals for water treatment and process) Thierry Brisard joined Neosens in June 2008. He aims to capitalize the fundamental values initiated by Laurent Auret, and to lead the company up to its financial independence. "Laurent Auret succeeded in developing and industrializing worldwide unique products which give a true response to current technical and sanitary industrial issues. My goal is to market these products that have been demonstrated to be industrially reliable, and to contribute in making Neosens a real business success. This will be achieved through an ambitious and responsible development of our sales activities, which can be realized now thanks to the renewed trust of our initial investors Sofinnova, Capricorn Cleantech Fund and ICSO. However, this goal can only be achieved if we stick to our people development process and to our core values: technical excellence, professionalism and customer care," says Thierry Brisard.
“In the process initiated several years ago for the reinforcement of management, the meeting with Thierry Brisard and especially the success of this transition are among the key events in the history of our company. Our duo, with its complementary skills and personalities, is the key element to achieve the goals we have set,” says Laurent Auret, who will continue to attend the Board of Directors.
This second round of funding will allow Neosens to continue financing both its development and marketing initiatives and fuel the company’s growth. The objectives will be also the development of next generation monitoring solutions, and the addition of new measurement techniques to its technological platform.
Press relations: Isabelle Girard
Tel: +33 (0) 5 61 75 62 47 - isabelle.girard@neo-sens.com
About Sofinnova Partners
Founded in Paris in 1972, Sofinnova Partners is one of Europe's leading independent venture capital firms. With € 900 million under management, Sofinnova Partners invests in start-ups and early-stage companies in technology and life sciences. Its investment strategy consists of investing early in teams and projects with high potential, most often acting as lead or co-lead investor. Sofinnova Partners also benefits from a long-established relationship with its sister company in San Francisco, Sofinnova Ventures. Sofinnova Partners’ teams bring valuable market insight and technical expertise to portfolio companies.
About Capricorn Cleantech Fund
Capricorn Cleantech Fund is an early to mid-stage venture capital fund managed by Capricorn Venture Partners. The fund invests in European growth companies developing innovative breakthrough technologies in the field of e.g. renewable energy and energy efficiency, water purification and re-use, bio-based material conversion and biorefinery platforms, clean air, climate change, green chemistry and advanced materials, materials recovery and recycling.
Capricorn Venture Partners NV, established in 1993, is a Leuven, Belgium based, independent manager of venture capital funds that focus on European companies with innovative technology as competitive advantage. The investment team of Capricorn is composed of experienced investment managers with deep technology expertise and a broad industrial experience.
For more information: www.capricorn.be
About ICSO Private Equity
ICSO Private Equity manages private equity funds (FCPR and FIP) dealing with venture capital, LBO and Growth capital. The 18-people team is member of the economic interest group IRDI and has been performing for 26 years.
Based in Toulouse and Bordeaux, ICSO Private Equity is the largest French independent regional actor. The company manages approximately € 200 million in assets, and invests from € 0.5 to 10 million in projects primarily in the West and South of France and in the North of Spain.
For more information: www.icso.fr
Contact: ICSO Private Equity (Jean-Michel Petit +33 (0)5 34 41 74 08)
Press: Sylvie Ives (+33 (0)6 84 14 11 15 - sylvie.ives@comm-in.fr)
About Galia Gestion
Galia Gestion is a regional venture capital company based in Bordeaux, managing FCPR and FIP, and mainly active in the South-West of France. Its main shareholder is the Caisse d’Epargne Aquitaine Poitou-Charentes. The company manages € 63 million of assets and invests amounts of € 0.2 to 2.5 million in creation, development or acquisition projects.
For more information: www.galia-gestion.com
SOFINNOVA PARTNERS Alessio Beverina
CAPRICORN VENTURE PARTNERS Marc Lambrechts
ICSO P.E./IRDI Jean-Michel Petit | Pantxika Passicot
GALIA GESTION Yves Bardinet
■ Legal Consulting Sébastien Burget (Stratene Avocats)
■ Legal Investment Consulting Anne Kerneur (Jones Day)
■ IP Audit Maxime Petit (Santarelli)
■ Financial Auditing Jean Pendanx (Attest Conseil)
2009
-
08/01/2009
Ablynx strengthens management team with the appointment of Dr Debbie Law as Chief Scientific Officer
-
09/01/2009
CoreValve Prevails in United Kingdom Patent Infringement Action
- 13/01/2009
- 13/01/2009
- 14/01/2009
-
15/01/2009
ReVolt Technology, Ltd Receives Additional 10 Million Euro B Round Investment
- 16/01/2009
- 20/01/2009
-
21/01/2009
Ablynx expands its musculoskeletal portfolio by taking P&G pharmaceuticals' programme in-house
- 21/01/2009
-
21/01/2009
DBV Technologies raises €6 million (EUR) in Series B investment and secures new corporate investor
- 21/01/2009
- 22/01/2009
- 28/01/2009
- 28/01/2009
-
04/02/2009
Inside Contactless and Sagem Wireless extend NFC Technology Partnership
- 05/02/2009
-
11/02/2009
NFC Technology Part of Qualcomm 3G Handset Reference Designs,
-
13/02/2009
Esmertec to acquire Purple Labs creating Europe’s largest mobile phone software company
-
23/02/2009
Sofinnova Partners realizes impressive exit with sale of portfolio company CoreValve to Medtronic
- 23/02/2009
-
17/02/2009
Tech tour seeks 'Best of French' emerging technology companies
-
05/03/2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
- 05/03/2009
- 03/03/2009
- 03/03/2009
- 10/03/2009
- 12/03/2009
- 17/03/2009
-
25/03/2009
Sofinnova Partners Voted 2008 “European Venture Capital Firm of the Year”
-
25/03/2009
Sofinnova Partners élu « Société de capital-risque européenne de l'année 2008 »
-
30/03/2009
Ablynx reports detailed positive phase Ib results for its anti-thrombotic Nanobody® ALX-0081
-
31/03/2009
First Data and Inside Contactless launch partnership for go-tag payment sticker technology
- 02/04/2009
- 08/04/2009
-
15/04/2009
Travel technology leader Sprice.com to power Sify's travel search
- 20/04/2009
-
13/04/2009
PC 30 | ITÉLÉ 13 AVRIL 09 20H30-21H - Vive les entreprises de service ?
-
21/04/2009
Neosens closes a second funding round of €4M
- 27/04/2009
- 27/04/2009
- 29/04/2009
- 07/05/2009
- 11/05/2009
- 15/05/2009
-
27/05/2009
U.S. Bank first to offer a single visa card for identification, purchases and secure facility access
-
28/05/2009
Inside debuts converged contactless payment/access control platform
- 30/05/2009
- 02/06/2009
- 28/05/2009
- 02/06/2009
- 02/06/2009
-
08/06/2009
NOXXON Announces Initiation of First Clinical Trial with a Spiegelmer®
-
19/06/2009
ReVolt Technology Selected as a Top-24 European Cleantech Leader
- 18/06/2009
-
22/06/2009
blueKiwi lève 3 millions d'euros auprès de Dassault Systèmes
- 23/06/2009
- 22/06/2009
- 26/06/2009
- 29/06/2009
- 29/06/2009
-
02/07/2009
PC30 reprend les activités « desktop » de SOGETI en Ile de France
- 02/07/2009
-
06/07/2009
Blue Kiwi | The Europas Shortlist: Best Enterprise / B2B Startup
- 08/07/2009
-
09/07/2009
ReVolt Technology, Ltd & BASF Announce Joint Development Agreement for Rechargeable Zinc-Air Battery
- 09/07/2009
- 09/07/2009
-
15/07/2009
INTERAC® Partners with Global Leader INSIDE to bring Contactless Debit to Canada
- 27/07/2009
-
27/07/2009
Orange to offer free gifts to students who agree to receive ads on mobiles
-
21/07/2009
Multek Enhances Touch Screen Solution Through Sensitive Object Strategic Alliance
- 30/07/2009
-
30/07/2009
Renforcement du conseil de surveillance de PC30 Jean Marie Descarpentries nommé Président
-
13/08/2009
Inside Contactless and cryptography research sign agreement to license DPA patents
-
12/08/2009
Upek launches developer contest for Windows 7 Biometric applications
- 12/08/2009
-
18/08/2009
Orexo announces that its partner Meda has initiated the launch of EdluarTM in the USA
- 18/08/2009
-
18/08/2009
Myriad Delivers Services Platform for Customer Service to T-Mobile
- 27/08/2009
-
28/08/2009
Orexo signs exclusive worldwide license agreement for a novel formulation
- 27/08/2009
- 28/08/2009
- 01/09/2009
- 01/09/2009
- 03/09/2009
- 01/09/2009
-
08/09/2009
Inside Contactless and Connecthings team to take NFC to the next level
-
09/09/2009
ReVolt Technology named a Global Cleantech 100 clean technology company
- 09/09/2009
-
10/09/2009
SFR a sélectionné WYPLAY pour sa prochaine génération de décodeurs TV
- 10/09/2009
-
09/09/2009
Engel and Wyplay parnter for next generation connected HD STB
-
11/09/2009
Myriad Introduces World’s First Widget Solution for Ultra-Low Cost Mobile Phones
- 14/09/2009
-
14/09/2009
Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)
- 15/09/2009
-
22/09/2009
Myriad Appoints Former Nokia Chief Technologist Benoit Schillings as Chief Technical Officer
-
22/09/2009
UPEK Expands Biometric Market with Launch of New TouchChip® Fingerprint Solutions
- 23/09/2009
-
28/09/2009
Addex complète le recrutement d’un premiere essai clinique intermédiare sur le RGO
-
28/09/2009
Addex completes enrollment of first mid-stage clinical GERD trial
-
28/09/2009
Upek launches new product line optimized for mobile phone applications
- 01/10/2009
- 01/10/2009
-
01/10/2009
Sofinnova Partners announces an agreement to sell Fovea Pharmaceuticals to Sanofi Aventis
-
01/10/2009
Ablynx receives milestone payment as part of its strategic alliance with Boehringer Ingelheim
-
06/10/2009
PUMA partners with Sagem Wireless to launch PUMA Mobile Phone
- 06/10/2009
-
12/10/2009
Crescendo Biologics Raises £4.5 million in Seed-Funding Led by Sofinnova Partners
- 12/10/2009
-
12/10/2009
Ablynx and Domantis settle their dispute and stop the arbitration process
-
15/10/2009
Protector Suite 2009 Software Adds Support for Windows 7 and the Windows Biometric Framework
-
15/10/2009
MicroPass 5100 “ICAO Lite” Products Compete for Best Identification Solution
-
15/10/2009
Accent - Itron Selects Accent Single Chip Solution for Smart Metering Applications
-
16/10/2009
Flexion Therapeutics Raises $33 Million in Series A Financing
- 19/10/2009
-
21/10/2009
Largest Retail Deployment of Contactless Loyalty Sticker Technology in France
- 22/10/2009
- 23/10/2009
-
26/10/2009
Sofinnova Partners Leads $12 Million Series A Round in DNP Green Technology
- 26/10/2009
- 27/10/2009
-
27/10/2009
Sagem Wireless collaborates with CRYSTALLIZED™ – Swarovski Elements
-
03/11/2009
Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference
- 03/11/2009
- 02/11/2009
- 02/11/2009
-
16/11/2009
Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
-
18/11/2009
Ablynx achieves third milestone in drug discovery and development collaboration
- 17/11/2009
-
19/11/2009
INSIDE Contactless wins in Semiconductor, Electronic and Components Category
-
03/12/2009
Movetis raises targeted €85 million in successful Initial Public Offering on Euronext Brussels
- 04/12/2009
-
03/12/2009
NOXXON Pharma AG Achieves Milestone in Partnership with Eli Lilly and Company
- 03/12/2009
-
03/12/2009
Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.
- 08/12/2009
- 04/12/2009
- 02/11/2009
- 14/12/2009
-
14/12/2009
Addex ends migraine prevention study Conference call tomorrow at 2pm CET (8am ET)
-
23/12/2009
Sofinnova Partners annonce sa troisième cession de plus de 500 millions de dollars pour l’année 2009
- 23/12/2009
-
26/11/2009
MasterCard Canada Brings PayPass™ Payments to BlackBerry Smartphones
-
23/12/2009
Sofinnova Partners Announces for the Third Time in 2009 a Trade Sale over 500 million dollars
-
23/12/2009
Movetis raises a total of €97.75m via an additional €12.75 million Over-allotment Option
-
22/12/2009
Ablynx demonstrates proof-of-concept by biomarker for its anti-thrombotic ALX-0081